Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations

Doron M. Behar, Daniel Garrigan, Matthew E. Kaplan, Zahra Mobasher, Dror Rosengarten, Tatiana Karafet, Lluis Quintana-Murci, Harry Ostrer, K. Skorecki, Michael F Hammer

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The molecular basis of more than 25 genetic diseases has been described in Ashkenazi Jewish populations. Most of these diseases are characterized by one or two major founder mutations that are present in the Ashkenazi population at elevated frequencies. One explanation for this preponderance of recessive diseases is accentuated genetic drift resulting from a series of dispersals to and within Europe, endogamy, and/or recent rapid population growth. However, a clear picture of the manner in which neutral genetic variation has been affected by such a demographic history has not yet emerged. We have examined a set of 32 binary markers (single nucleotide polymorphisms; SNPs) and 10 microsatellites on the non-recombining portion of the Y chromosome (NRY) to investigate the ways in which patterns of variation differ between Ashkenazi Jewish and their non-Jewish host populations in Europe. This set of SNPs defines a total of 20 NRY haplogroups in these populations, at least four of which are likely to have been part of the ancestral Ashkenazi gene pool in the Near East, and at least three of which may have introgressed to some degree into Ashkenazi populations after their dispersal to Europe. It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability, especially in those founder haplogroups that migrated from the Near East. This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity.

Original languageEnglish (US)
Pages (from-to)354-365
Number of pages12
JournalHuman Genetics
Volume114
Issue number4
DOIs
StatePublished - Mar 2004

Fingerprint

Y Chromosome
Single Nucleotide Polymorphism
Population
Middle East
Population Density
Gene Pool
Genetic Drift
Mutation
Inborn Genetic Diseases
Population Growth
Microsatellite Repeats
Demography
Incidence

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations. / Behar, Doron M.; Garrigan, Daniel; Kaplan, Matthew E.; Mobasher, Zahra; Rosengarten, Dror; Karafet, Tatiana; Quintana-Murci, Lluis; Ostrer, Harry; Skorecki, K.; Hammer, Michael F.

In: Human Genetics, Vol. 114, No. 4, 03.2004, p. 354-365.

Research output: Contribution to journalArticle

Behar, DM, Garrigan, D, Kaplan, ME, Mobasher, Z, Rosengarten, D, Karafet, T, Quintana-Murci, L, Ostrer, H, Skorecki, K & Hammer, MF 2004, 'Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations', Human Genetics, vol. 114, no. 4, pp. 354-365. https://doi.org/10.1007/s00439-003-1073-7
Behar, Doron M. ; Garrigan, Daniel ; Kaplan, Matthew E. ; Mobasher, Zahra ; Rosengarten, Dror ; Karafet, Tatiana ; Quintana-Murci, Lluis ; Ostrer, Harry ; Skorecki, K. ; Hammer, Michael F. / Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations. In: Human Genetics. 2004 ; Vol. 114, No. 4. pp. 354-365.
@article{534843e5ad054ca197b6bf568b61461b,
title = "Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations",
abstract = "The molecular basis of more than 25 genetic diseases has been described in Ashkenazi Jewish populations. Most of these diseases are characterized by one or two major founder mutations that are present in the Ashkenazi population at elevated frequencies. One explanation for this preponderance of recessive diseases is accentuated genetic drift resulting from a series of dispersals to and within Europe, endogamy, and/or recent rapid population growth. However, a clear picture of the manner in which neutral genetic variation has been affected by such a demographic history has not yet emerged. We have examined a set of 32 binary markers (single nucleotide polymorphisms; SNPs) and 10 microsatellites on the non-recombining portion of the Y chromosome (NRY) to investigate the ways in which patterns of variation differ between Ashkenazi Jewish and their non-Jewish host populations in Europe. This set of SNPs defines a total of 20 NRY haplogroups in these populations, at least four of which are likely to have been part of the ancestral Ashkenazi gene pool in the Near East, and at least three of which may have introgressed to some degree into Ashkenazi populations after their dispersal to Europe. It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability, especially in those founder haplogroups that migrated from the Near East. This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity.",
author = "Behar, {Doron M.} and Daniel Garrigan and Kaplan, {Matthew E.} and Zahra Mobasher and Dror Rosengarten and Tatiana Karafet and Lluis Quintana-Murci and Harry Ostrer and K. Skorecki and Hammer, {Michael F}",
year = "2004",
month = "3",
doi = "10.1007/s00439-003-1073-7",
language = "English (US)",
volume = "114",
pages = "354--365",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations

AU - Behar, Doron M.

AU - Garrigan, Daniel

AU - Kaplan, Matthew E.

AU - Mobasher, Zahra

AU - Rosengarten, Dror

AU - Karafet, Tatiana

AU - Quintana-Murci, Lluis

AU - Ostrer, Harry

AU - Skorecki, K.

AU - Hammer, Michael F

PY - 2004/3

Y1 - 2004/3

N2 - The molecular basis of more than 25 genetic diseases has been described in Ashkenazi Jewish populations. Most of these diseases are characterized by one or two major founder mutations that are present in the Ashkenazi population at elevated frequencies. One explanation for this preponderance of recessive diseases is accentuated genetic drift resulting from a series of dispersals to and within Europe, endogamy, and/or recent rapid population growth. However, a clear picture of the manner in which neutral genetic variation has been affected by such a demographic history has not yet emerged. We have examined a set of 32 binary markers (single nucleotide polymorphisms; SNPs) and 10 microsatellites on the non-recombining portion of the Y chromosome (NRY) to investigate the ways in which patterns of variation differ between Ashkenazi Jewish and their non-Jewish host populations in Europe. This set of SNPs defines a total of 20 NRY haplogroups in these populations, at least four of which are likely to have been part of the ancestral Ashkenazi gene pool in the Near East, and at least three of which may have introgressed to some degree into Ashkenazi populations after their dispersal to Europe. It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability, especially in those founder haplogroups that migrated from the Near East. This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity.

AB - The molecular basis of more than 25 genetic diseases has been described in Ashkenazi Jewish populations. Most of these diseases are characterized by one or two major founder mutations that are present in the Ashkenazi population at elevated frequencies. One explanation for this preponderance of recessive diseases is accentuated genetic drift resulting from a series of dispersals to and within Europe, endogamy, and/or recent rapid population growth. However, a clear picture of the manner in which neutral genetic variation has been affected by such a demographic history has not yet emerged. We have examined a set of 32 binary markers (single nucleotide polymorphisms; SNPs) and 10 microsatellites on the non-recombining portion of the Y chromosome (NRY) to investigate the ways in which patterns of variation differ between Ashkenazi Jewish and their non-Jewish host populations in Europe. This set of SNPs defines a total of 20 NRY haplogroups in these populations, at least four of which are likely to have been part of the ancestral Ashkenazi gene pool in the Near East, and at least three of which may have introgressed to some degree into Ashkenazi populations after their dispersal to Europe. It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability, especially in those founder haplogroups that migrated from the Near East. This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity.

UR - http://www.scopus.com/inward/record.url?scp=12144291681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144291681&partnerID=8YFLogxK

U2 - 10.1007/s00439-003-1073-7

DO - 10.1007/s00439-003-1073-7

M3 - Article

VL - 114

SP - 354

EP - 365

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 4

ER -